Colin Berry

Colin Berry

Interventional cardiologist / Cardiologist
Golden Jubilee National Hospital - Clydebank, United Kingdom

Latest contributions

A journey into the ANOCA and INOCA dilemma

21 May 2025 – From EuroPCR 2025

Explore the complex clinical dilemma of ANOCA and INOCA with focus on angina endotypes, prognostic stratification, metabolic phenotype associations, and microvascular function assessment using indices such as microcirculatory resistance and microvascular resistance reserve.

A journey into the ANOCA and INOCA dilemma

When coronary angiography is not enough

20 May 2025 – From EuroPCR 2025

Dive into the complexities that arise when coronary angiography alone is insufficient. This session explores comprehensive physiology and imaging assessments in INOCA with ventricular fibrillation, repeat coronary events, acetylcholine testing for epicardial spasm, and invasive physiology to stratify angina therapy.

When coronary angiography is not enough

Contemporary challenges in acute coronary syndromes

20 May 2025 – From EuroPCR 2025

Examine contemporary challenges in acute coronary syndromes (ACS) through recent trials and studies. Topics include long-term outcomes of deferred stenting, thrombectomy techniques, PCI in cardiogenic shock, and revascularisation strategies, providing a comprehensive update for clinical practice.

Contemporary challenges in acute coronary syndromes

Management of MINOCA patients

15 May 2024 – From EuroPCR 2024

Management of MINOCA patients

Contemporary management of patients with INOCA: a practical guide

17 May 2023 – From EuroPCR 2023

Enrich your understanding of ischemia with non-obstructive corona arteries (INOCA) by watching this very practical session, where you'll discover precious knowledge on the prevalence and causative factors of this condition. Dive into the diagnosis algorithm used for INOCA and explore the latest advancements in its management.

Contemporary management of patients with INOCA: a practical guide

PCR Perspectives - a contemporary approach to the invasive diagnosis of MINOCA

17 May 2023 – From EuroPCR 2023

Nina Van Der Hoeven and Colin Berry seize the opportunity of meeting at the heart of EuroPCR 2023 to discuss the diagnostic approach of MINOCA. As they explain, everything is primarily determined in the cathlab, thanks to angiograms. Further investigations are then required to exclude other causes than...

PCR Perspectives - a contemporary approach to the invasive diagnosis of MINOCA

The many faces of MINOCA: a guide for everyday practice

16 May 2023 – From EuroPCR 2023

In this session, find out more about MINOCA mechanisms and diagnostic approach tools, study SCAD and plaque rupture/erosion, and see how intracoronary imaging can be useful, view coronary spasm and acetylcholine testing, and analyze structured approach in MINOCA patients.

The many faces of MINOCA: a guide for everyday practice

What causes INOCA?

17 Dec 2020

Watch now C. Berry, C. Collet , J. Escaned and J. Tremmel in this series of webinars on ischemia and no obstructive coronary artery disease

The problem of INOCA

29 Nov 2020

Watch now J. Escaned, C. Berry and A. Maas in this series of webinars on ischemia and no obstructive coronary artery disease

Closing the loop of coronary physiology: from FFR to microvascular resistance reserve (​MRR)

14 Dec 2021

Watch the replay of this PCR Webinar on coronary physiology with J. Escaned , C. Berry, B. De Bruyne and N. HJ Pijls

Best of the European Heart Journal

19 May 2021 – From EuroPCR 2021

Watch this session, originally presented during EuroPCR 2021 by F. Crea, Editor-in-chief, and C. Berry, Executive Editor, to find out more, both about the most cited European Heart Journal original research article, and the most Almetric scored one, and enjoy in-depth analysis of the SOLVE-TAVI and DAEDALUS studies in...

Best of the European Heart Journal

Current evidence for the interventional treatment of INOCA patients

26 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to understand how Reducer therapy can help the interventionalist safely improve symptoms of his "end stage" patient, to recognize that microvascular disease is common and has poor prognosis and to understand how Reducer therapy can address patients with microvascular disease.

Current evidence for the interventional treatment of INOCA patients

Coronary Microvascular Dysfunction: Why diagnosis in the Cathlab does matter

26 Jun 2020 – From PCR e-Course 2020

Watch this session to learn more about the prevalence of coronary microvascular dysfunction & angina, and to learn why diagnosis of coronary microvascular dysfunction is so important.

Coronary Microvascular Dysfunction

All you need to know about physiological assessment of coronary artery disease

21 May 2019 – From EuroPCR 2019

Consult this session to learn all about the physiological assessment of coronary artery disease, thanks to a comprehensive and clinically relevant update on this field and to an identification of the current guidelines and recommendations, leading to further questions that will need to be addressed in the...

All you need to know about physiological assessment of coronary artery disease